Fairvalue-Calculator Fairvalue-Calculator
EN DE

PT Kalbe Farma Tbk., (PTKFF) Fair Value & Analysis

Healthcare · US · Market cap $1.8B

Price$0.0403
Fair Value$0.0764
Upside+89.7%
Quality88/100
Evidence: Medium Range $0.0563 – $0.1006

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

PT Kalbe Farma Tbk., (PTKFF) currently trades at $0.0403, while our model-based Fair Value estimate is $0.0764 — implying the stock looks roughly 89.7% undervalued today. We read business quality at 88/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia.

Open the full interactive analysis →

Similar stocks

Eli Lilly and Company (LLY) -60% Johnson & Johnson, (JNJ) -32% AbbVie Inc (ABBV) -52% Roche Holding (ROGN) -20% Merck & Co (MRCK34) -82% AstraZeneca PLC (A1ZN34) -85%

Frequently asked questions

Is PT Kalbe Farma Tbk., (PTKFF) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0764 versus a price of $0.0403 — about +90% (undervalued). Model-based estimate, not financial advice.
What is the fair value of PTKFF?
Our 21-model fair value for PT Kalbe Farma Tbk., is $0.0764 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0403.
What is the quality score of PTKFF?
PT Kalbe Farma Tbk., has a Quality Score of 88/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.